The Medicines and Healthcare products Regulatory Agency (MHRA) and the National Institute for Health and Care Excellence (NICE) have launched a call for evidence to evaluate the impact of resources developed under the Wellcome-funded Digital Mental Health Technologies (DMHT) programme. The survey opened on 5 November 2026 and will remain open until 26 February 2027, a window of just under four months.
The exercise forms part of the programme's Phase 1 evaluation. According to the two organisations, it aims to assess how the resources have been received and used across the sector, and they say they are particularly interested in whether the materials have influenced users' knowledge, confidence, decision-making and professional practice.
Who the call is aimed at
The MHRA and NICE are seeking feedback from a wide range of stakeholders rather than from a single professional group. The intended respondents are:
- developers and manufacturers of digital mental health technologies;
- healthcare professionals;
- researchers, policymakers and regulators;
- people with lived experience of mental health conditions, carers and members of the public.
Stakeholders are encouraged to take part whether they have engaged extensively with the existing resources, minimally, or not at all. That framing means the evaluation is intended to capture views from outside the current user base as well as from organisations and individuals who have already worked with the materials.
The resources are aimed at those who build, assess or adopt these tools, which is why the call spans industry, clinical practice, research, policy and regulation as well as people with direct experience of mental health conditions.
Purpose of the resources under review
The resources were developed to support the safe development, regulation, evaluation and adoption of digital mental health technologies, a category that includes mental health apps and other digital tools. The survey focuses on the Phase 1 outputs and on whether they have achieved their intended objectives.
Findings will also help determine the future direction of Phase 2 of the DMHT programme. The MHRA and NICE say the feedback will help identify strengths, highlight areas for improvement and shape future work to improve the safety and effectiveness of digital mental health technologies.
Timing and open questions
The consultation period runs from 5 November 2026 to 26 February 2027. The announcement does not set out a publication date for the evaluation findings, nor a start date for Phase 2, so the point at which the survey results will feed into the programme's next stage is not yet fixed in the public materials.
For developers and manufacturers, the call offers a route to comment on how the Phase 1 materials have functioned in practice. For clinicians and researchers, it covers whether the resources changed knowledge, confidence or professional practice. The two organisations say responses will be used to identify strengths, highlight areas for improvement and shape future work.